Home / GARNL3 Knockout Cell Lines

GARNL3 Knockout Cell Lines

Gene: GARNL3

Official Full Name: GTPase activating Rap/RanGAP domain like 3provided by HGNC

Gene Summary: Predicted to enable GTPase activator activity. Predicted to be involved in regulation of small GTPase mediated signal transduction. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO25051 GARNL3 Knockout cell line (HeLa) Human GARNL3 1:3~1:6 Negative Online Inquiry
KO25052 GARNL3 Knockout cell line (HCT 116) Human GARNL3 1:2~1:4 Negative Online Inquiry
KO25053 GARNL3 Knockout cell line (HEK293) Human GARNL3 1:3~1:6 Negative Online Inquiry
KO25054 GARNL3 Knockout cell line (A549) Human GARNL3 1:3~1:4 Negative Online Inquiry

Background

GARNL3 Gene Knockout Cell Lines are precisely engineered cell lines created through targeted gene editing techniques, specifically CRISPR/Cas9, to produce a functional absence of the GARNL3 gene. This innovative tool allows researchers to study the physiological and pathological roles of the GARNL3 gene in various cellular contexts, providing deeper insights into its biological functions and implications in diseases.

The primary function of GARNL3 knockout cell lines is to enable the investigation of the gene's contributions to cellular pathways, processes such as cell growth, differentiation, and response to stressors. By removing the GARNL3 gene, researchers can elucidate its role in cellular mechanisms, potentially unveiling connections to diseases, including cancer and metabolic disorders. The use of these knockout models facilitates the identification of gene interactions and the exploration of compensatory mechanisms that may arise in the absence of GARNL3.

Scientifically, the GARNL3 Gene Knockout Cell Lines hold significant importance in both research and clinical applications. They can be utilized in drug discovery processes, allowing researchers to test therapeutics in a controlled environment that lacks the influence of the GARNL3 protein. Additionally, these models can simulate pathological conditions, making them invaluable for studying disease phenotypes and validating potential therapeutic targets.

Compared to traditional methods such as RNA interference, GARNL3 knockout cell lines provide a more stable and permanent gene disruption, offering clarity in experimental outcomes. Their specificity and reliability distinguish them from other models, reducing the likelihood of off-target effects that could confound results. Furthermore, these cell lines can be tailored to meet the needs of various research projects, providing versatility for scientists working in multidisciplinary fields.

For researchers and clinicians, the GARNL3 Gene Knockout Cell Lines offer undeniable value by facilitating high-quality, reproducible research that addresses critical questions in cell biology and medicine. They serve as a pivotal resource for advancing our understanding of gene functions and their implications in health and disease.

At [Your Company Name], we pride ourselves on delivering cutting-edge biological tools that empower scientists to push the boundaries of discovery. Our expertise in gene editing technologies ensures that our GARNL3 Gene Knockout Cell Lines are of the highest quality and reliability, supporting researchers in their quest to uncover the complexities of human biology.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.